El primer episodio estará dedicado a uno de los grandes campos de la innovación a nivel mundial, uno de los que más dudas y controversias genera y que, en tiempos de pandemia y de vacunas, está de plena actualidad. Hablaremos de las patentes biotecnológicas con la participación de Nicolás Vincent Ruiz, Global Intellectual Property Head de ESTEVE, junto a Patricia Ramos, directora Área Patentes PONS IP y Ana Herrera Arroyo, responsable de Biotecnología del Área Patentes PONS IP a la que también hemos entrevistado. Para la firma invitada, contaremos con la participación de José Antonio Gil Celedonio, director de la Oficina Española de Patentes y Marcas (OEPM).
IP newsthat
may interest you
by Jose Carlos Erdozain, Of Counsel PONS IP Phenomena such as Mary of Gold (Finding Me Again has surpassed 4 million streams on Spotify alone) or Breaking Rust (an AI-generated country music project whose track Walk My Walk has accumulated...
By Isabel Cortés. Head of Institutional Projects and Relations. Trademark Attorney PONS IP The rapid growth of generative artificial intelligence has changed how digital content is created, shared and consumed. From AI-generated images and synthetic voices to highly realistic videos of...
Patents, designs and trade marks underpin almost half of Europe’s GDP, yet they still carry little weight when companies seek financing. Brussels wants to reverse this situation, and businesses should start preparing now. By Manuel Campanero Carrasco, Economist. Director of...
NEWSLETTER
All the IP News
in your e-mail
Find out all the latest information on IP to boost the development of your organisation.
Subscribe to our bimonthly newsletter
International Awards
and Recognitions


